Rational therapy and modern principles of diagnostics of iron-deficient states in obstetric and gynecological practice


Cite item

Full Text

Abstract

The article details the current state of problem of anemia and iron deficiency anemia (IDA) in obstetrics and gynecology. It has been established that the IDA is the third most common cause of temporary disability among women aged 15-44 years. The data for the epidemiology of IDA, the mechanisms of iron metabolism, etiology of IDA, clinical presentations of the disease, the principles of its diagnosis, prevention and treatment are presented. It is noted that the Ferretab drug, widely used by the authors for the treatment and prevention of IDA in gynecologic patients, conform to modern requirements for iron preparations. The authors consider Ferretab characteristics and application rules.

References

  1. Аркадьева Г.В. Диагностика и лечение железодефицитных анемий. М., 1999. 58 с.
  2. Дворецкий Л.И. ЖДА. М., 1998.
  3. Шехтман М.М. В кн.: Экстрагенитальная патология и беременность. М., 1987. С. 143-155.
  4. Ковалева Л. Железодефицитная анемия // Врач. 2002. № 12. С.4-9.
  5. Серов В.Н., Орджоникидзе Н.В. Анемия - акушерские и перинатальные аспекта // РМЖ. 2004. Т. 12. № 1 (201). С. 12-15.
  6. Perewusnyk G, Huch R, Huch A, et al. Parenteral iron therapy in obstetrics: 8 years experience with iron-sucrose complex. Br J Nutr 2002;(88):3-10.
  7. Шеффер Р.М., Гаше К., Хух Р. и др. Железное письмо: рекомендации по лечению железодефицитной анемии // Гематология и трансфузиология. 2004. № 49 (4). С. 40-48.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2009 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies